GSA Capital Partners LLP Invests $936,000 in HCA Healthcare, Inc. $HCA

GSA Capital Partners LLP acquired a new stake in HCA Healthcare, Inc. (NYSE:HCA) during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 2,197 shares of the company’s stock, valued at approximately $936,000.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Cerity Partners LLC boosted its position in shares of HCA Healthcare by 13.1% during the third quarter. Cerity Partners LLC now owns 43,920 shares of the company’s stock worth $18,719,000 after buying an additional 5,092 shares during the period. Swiss National Bank grew its stake in shares of HCA Healthcare by 4.3% during the 2nd quarter. Swiss National Bank now owns 558,900 shares of the company’s stock worth $214,115,000 after acquiring an additional 23,100 shares in the last quarter. Savant Capital LLC lifted its position in shares of HCA Healthcare by 37.7% in the third quarter. Savant Capital LLC now owns 4,548 shares of the company’s stock worth $1,938,000 after purchasing an additional 1,246 shares in the last quarter. Sector Gamma AS increased its stake in HCA Healthcare by 36.0% in the 3rd quarter. Sector Gamma AS now owns 10,883 shares of the company’s stock valued at $4,638,000 after buying an additional 2,883 shares during the last quarter. Finally, National Pension Service boosted its stake in shares of HCA Healthcare by 2.9% during the 3rd quarter. National Pension Service now owns 626,585 shares of the company’s stock worth $267,051,000 after buying an additional 17,531 shares during the last quarter. 62.73% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several brokerages recently commented on HCA. Robert W. Baird increased their price target on HCA Healthcare from $423.00 to $450.00 and gave the company a “neutral” rating in a research report on Thursday, December 11th. Wells Fargo & Company raised their target price on shares of HCA Healthcare from $452.00 to $481.00 and gave the company an “equal weight” rating in a research note on Friday, January 30th. Weiss Ratings reiterated a “buy (b)” rating on shares of HCA Healthcare in a research note on Monday, December 29th. Cantor Fitzgerald raised their target price on shares of HCA Healthcare from $525.00 to $588.00 and gave the company an “overweight” rating in a research note on Wednesday, January 28th. Finally, Barclays upped their price objective on HCA Healthcare from $494.00 to $551.00 and gave the company an “overweight” rating in a research note on Wednesday, January 28th. Sixteen investment analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, HCA Healthcare currently has a consensus rating of “Moderate Buy” and a consensus price target of $530.77.

HCA Healthcare Stock Performance

HCA stock opened at $532.98 on Friday. HCA Healthcare, Inc. has a 52 week low of $295.00 and a 52 week high of $552.90. The company’s 50-day simple moving average is $488.01 and its 200 day simple moving average is $454.46. The company has a market capitalization of $119.19 billion, a PE ratio of 18.78, a price-to-earnings-growth ratio of 1.62 and a beta of 1.36.

HCA Healthcare (NYSE:HCA) last announced its earnings results on Tuesday, January 27th. The company reported $8.01 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.37 by $0.64. The firm had revenue of $19.51 billion for the quarter, compared to analyst estimates of $19.67 billion. HCA Healthcare had a net margin of 8.97% and a negative return on equity of 409.11%. The business’s revenue was up 6.7% compared to the same quarter last year. During the same quarter in the prior year, the business posted $6.22 EPS. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, analysts forecast that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, March 31st. Stockholders of record on Tuesday, March 17th will be issued a dividend of $0.78 per share. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.72. The ex-dividend date of this dividend is Tuesday, March 17th. This represents a $3.12 annualized dividend and a dividend yield of 0.6%. HCA Healthcare’s payout ratio is currently 10.15%.

Key HCA Healthcare News

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: HCA is expanding emergency access through local partnerships and new freestanding ERs, which can increase lower‑acuity, higher‑margin volumes and outpatient revenue. Read More.
• Positive Sentiment: HCA opened a new ER site (Shoppes at Mission Trace) — incremental access points support ambulatory/ER growth. Read More.
• Positive Sentiment: Analyst and momentum coverage is favorable: Zacks highlights HCA as a momentum name and JPMorgan raised its price target to $535 (neutral rating but higher target), both of which can attract investor flows. Read More. — Read More.
• Neutral Sentiment: Local human‑interest/community health stories (neonatal success, suicide‑prevention grant) are positive for brand but unlikely to move the stock materially. Read More. — Read More.
• Neutral Sentiment: Leadership moves (new chief nurse in Houston; four new leaders in Alaska) are operational/clinic-level changes that support execution but are not major catalysts on their own. Read More. — Read More.
• Negative Sentiment: A nurse sued HCA Florida Palms West Hospital and a security company after a violent patient attack — litigation and safety concerns can raise reputational risk and potential costs. Read More.
• Negative Sentiment: Critical opinion pieces highlight continued safety concerns at Mission Hospital; sustained negative media about safety can pressure sentiment and invite regulatory/survey scrutiny. Read More.
• Negative Sentiment: Insider selling disclosed: EVP Michael McAlevey sold ~1,694 shares (~$903K). While single insider sales often reflect personal liquidity, markets sometimes view such moves as a minor negative signal. Read More.

Insider Buying and Selling

In related news, EVP Michael R. Mcalevey sold 1,694 shares of the company’s stock in a transaction dated Wednesday, February 18th. The shares were sold at an average price of $533.37, for a total transaction of $903,528.78. Following the completion of the sale, the executive vice president owned 8,853 shares of the company’s stock, valued at $4,721,924.61. This represents a 16.06% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, EVP Michael S. Cuffe sold 1,500 shares of the company’s stock in a transaction that occurred on Tuesday, February 3rd. The stock was sold at an average price of $498.09, for a total transaction of $747,135.00. Following the sale, the executive vice president directly owned 30,003 shares of the company’s stock, valued at approximately $14,944,194.27. This trade represents a 4.76% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 15,214 shares of company stock worth $7,797,595 in the last ninety days. 1.30% of the stock is owned by company insiders.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.